|
|||||
|
|
Aging-associated increase in indoleamine 2,3-dioxygenase (IDO) activity appears to be unrelated to the transcription of the IDO1 or IDO2 genes in peripheral blood mononuclear cells |
|
| Authors: | Saara Marttila Juulia Jylhävä Carita Eklund Antti Hervonen Marja Jylhä Mikko Hurme |
| Affiliation: | 1. Department of Microbiology and Immunology, The School of Medicine, University of Tampere, Kragujevac, Finland 2. The School of Health Sciences, University of Tampere, Kragujevac, Finland 3. Centre for Laboratory Medicine, Tampere University Hospital, Kragujevac, Finland |
| Abstract: | BackgroundOld age is associated with increased levels of circulating pro-inflammatory cytokines, a phenomenon termed inflamm-aging. Elevated levels of pro-inflammatory cytokines have been associated with several age-associated diseases and with a shortened lifespan. Indoleamine 2,3-dioxygenase (IDO) has immunomodulatory properties and its activity is elevated in inflammation, autoimmune disorders and malignancies. We have previously shown that IDO activity is increased in nonagenarians compared to young individuals and that high IDO activity is associated with mortality at old age.FindingsIn this study our aim was to assess whether this difference in IDO activity in the plasma was due to the differential expression of either the IDO1 or IDO2 gene in peripheral blood mononuclear cells. Our results show that IDO1 and IDO2 are not differently expressed in nonagenarians compared to controls and that the expression of IDO genes is not associated with the level of IDO activity in the plasma.ConclusionThe level of IDO activity in the plasma is not regulated through the expression of IDO1 or IDO2 in the peripheral blood mononuclear cells. |
| Keywords: | |
| 本文献已被 SpringerLink 等数据库收录！ | |